Meeting
2015 ASCO Annual Meeting
Adjuvant chemotherapy for patients with T2N0M0 non-small cell lung cancer.
Authors
Daniel Morgensztern
Washington University School of Medicine in St. Louis, St. Louis, MO
Daniel Morgensztern , Saiama Naheed Waqar , Aalok Patel , Siddhartha Devarakonda , Sadaf Huma Waqar , Feng Gao , Cliff Grant Robinson , Jeffrey D. Bradley , Maria Quintos Baggstrom , Ramaswamy Govindan , Varun Puri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 33, 2015 (suppl; abstr 7520)
DOI
10.1200/jco.2015.33.15_suppl.7520
Abstract #
7520
Poster Bd #
267
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
The use of adjuvant chemotherapy in resected stage IB-IIIA non–small cell lung cancer (NSCLC) and comparison to the TriNetX database.
First Author: Ayesha Shameem
Poster
2020 ASCO Virtual Scientific Program
Role of adjuvant chemotherapy in patients with pathological stage I NSCLC with high-risk features.
First Author: Lubina Arjyal
Poster
2012 ASCO Annual Meeting
Pilot SCAT trial: Spanish customized adjuvant chemotherapy (CT) based on BRCA1 mRNA expression levels (l) in resected stage II-IIIA non-small cell lung cancer (NSCLC) patients (p).
First Author: Jose Miguel Sanchez
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world impact on overall survival of oxaliplatin-based adjuvant chemotherapy in older patients with colorectal cancer in Mexico.
First Author: Marytere Herrera